Dmitry Balyasny’s Cellectis CLLS Stock Holding History

Dmitry Balyasny’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-19,400	Closed	-$552K	–	2081
2017 Q3	$552K	Buy	+19,400	New	+$502K	﹤0.01%	1331

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dmitry Balyasny's CLLS Position: Q4 2022 in Review

Dmitry Balyasny sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 18,352 shares — an estimated $42K sold.

Dmitry Balyasny first reported a position in CLLS in Q4 2015 and held it in 5 quarters. The position peaked at $11.9M in Q4 2017. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

Dmitry Balyasny reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
Dmitry Balyasny sold 18,352 Cellectis shares in Q4 2022, an estimated $42K.
Dmitry Balyasny first reported a position in Cellectis in Q4 2015 and held it in 5 quarters.
Dmitry Balyasny's Cellectis position peaked at $11.9M in Q4 2017.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.